Giuliana Grossi

Because vasculitis can manifest in various ways, Matthew Koster, MD, talks about identifying Granulomatosis with polyangiitis and other forms of the disease.

Tanaz Kermani, MD, MS, talks about the current state of vasculitis care and the latest research in the field.

An overview of the progress in hemophilia treatments and global access to gene therapy.

Investigators address the need for understanding surrounding the relationship between poor bone health and patients who are hemophilia carriers and those with von Willebrand disease.

A new study evaluates the prognostic potential of exercise testing for patients with sickle cell disease.

After 15 years and 18 patents, the new biotechnology developed by Ariste Medical receives FDA approval to assist in healing ventral hernia repair, one of the most common surgeries.

Positive preliminary biomarker data were reported from the first cohort in the phase 1 portion of the trial.

Barriers to sickle cell disease care are identified across multiple levels including individual, family, provider, and socio-environmental levels according to patient perspectives.

In an interview, Karen Kozarsky, CSO of SwanBio discusses the new data being presented at AAN on AAV-based gene therapy candidate SBT101.

At the AAN 2022 Annual Meeting, SwanBio presents new data regarding lead candidate SBT101 for treating adrenomyeloneuropathy, a rare debilitating disease with no approved therapies.

Dr. Rafael Pérez-Figueroa talks about how the pandemic has exacerbated racial inequities on multiple levels saying that people of color have been overrepresented in jobs with high exposure to COVID-19, leading to disproportionate infections and death.

The NaV1.8 inhibitor VX-548 shows promising potential as a non-opioid acute pain treatment.

Late use of steroids among patients with AIN shows now indication of further recovery and poses an additional risk of exposing patients to adverse effects.

Patients with psoriatic arthritis and ankylosing spondylitis experienced rapid pain reduction with upadacitinib, regardless of treatment history.

Investigators conducted the largest study on SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.

From the struggle of obtaining insurance approvals to addressing the nationwide shortage of rheumatologists, Dr. Baker Frost talks about her experience treating patients with autoimmune disease.

Bristol Myers Squibb has to wait 3 months for FDA decision on Reblozyl for treating non-transfusion-dependent β-thalassemia.

Expert John Sergent shares insight on his best practices treating patients with autoimmune diseases.

In honor of Autoimmune Disease Awareness Month, expert Dr. Joe Ahearn and advocate Michael Linn discuss relapsing polychondritis.

Interstitial lung disease expert explains the importance of educating patients with autoimmune disease.

Authors call for further investigation of pathophysiological pathways between rheumatoid arthritis and primary open-angle glaucoma.

Patients with Fabry disease who received treatment with PRX-102 every 4 weeks displayed a stable condition at the end of the trial.

Authors of the study on PRP in knee osteoarthritis addressed the concerns shared by physicians in response to the method of their research.

A summarization of the in-depth review, editorial and synopsis provided by multiple experts after revising the updates to the VA/DoD joint clinical practice guideline for substance use disorders.

In 2020 many clinics shifted to telehealth or reduced-contact practices which applied to medication abortions. Physicians relied solely on history-based screening instead of ultrasonography or pelvic exams during this time and investigators analyzed the data.

Because Sjögren's Syndrome is often undetected or misdiagnosed, investigators developed the Sjögren's Syndrome Screening Questionnaire (SSSQ).

Investigators in Israel perform the largest retrospective review of patients with rheumatic fever in a developed country, spanning 25 years of research.

The use and legalization of cannabis products has been increasing in the US for a variety of medical concerns. Investigators aim to better understand the risks and benefits of owning a medical marijuana card.

The results lead investigators to question the usefulness of prehabilitation before total knee replacement to improve functional outcomes in patients with osteoarthritis.